The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building a stake in the Ozempic maker.

Medicamento e demais fármacos liberados integram nova diretriz para tratamento da doença no Brasil; avaliação médica continua ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

Valores reduzidos passam a valer nesta segunda-feira, 2, em plataformas de e-commerce e lojas físicas de grandes redes de ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy. Competitors are nipping at its heels, cheaper knockoffs have been eating into ...

In recent months, a staggering number of women, particularly on social media, have been sharing their experiences with Ozempic, a drug that was originally developed to treat type 2 diabetes.

PLAINSBORO, N.J., May 22, 2025 /PRNewswire/ -- Today, as the US Food and Drug Administration (FDA) grace period for mass compounding of "semaglutide" expires, Novo Nordisk announced a series of ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S ...

Goldstein said he's filed one lawsuit to date in Middlesex, New Jersey, home to Novo Nordisk, the manufacturer of Ozempic and Wegovy, and plans to file others in the coming weeks. Get the latest ...